VC firm
Monograph Capital
- Investor type
- VC
- Investing status
- Activeas of 2026-09-19Source (opens in a new tab)
- Headquarters
- San Francisco, CA, United States
- Founded
- 2021
- Assets under management
- $325MForm ADV private fund GAV, as of 2026-03-25Source (opens in a new tab)
- Funds
- 2
- Legal name
- MONOGRAPH CAPITAL ADVISORS, L.P.
Claim, correct or request removal
Record updated 29 September 2026
About
We are Monograph Capital. We find and fund innovative life sciences companies, aiming to help translate promising science into potential, life-changing treatments for patients around the world.
Investment approach
- Thesis
- We are a transatlantic team focused on sourcing leading scientific innovation and supporting the development of strong companies across boundaries. We combine differentiated sourcing, long-standing relationships with pharma, deep medical expertise, and seasoned operating experience to help create value for our company partners and investors, with a goal of improving health outcomes for patients over time.Source (opens in a new tab)
- Investing status notes
- We find and fund innovative life sciences companies, aiming to help translate promising science into potential, life-changing treatments for patients around the world.
Funds
- MONOGRAPH CAPITAL PARTNERS II, L.P.
- Main fund
- MONOGRAPH CAPITAL PARTNERS I, L.P.
- Main fund
SEC registration
- Registered adviser
- MONOGRAPH CAPITAL ADVISORS, L.P.
- CRD number
- 315988 (opens in a new tab)
- SEC file number
- 802-122325
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $325Mas of 2026-03-25
- Private funds reported
- 2
- Principal office
- SAN FRANCISCO, CA, United States
Locations
- Office
- London
- Office
- San Francisco, CA
Loading relationship preview